Cholesterol and Blood Pressure Regulating Pathways

The term “Cholesterol and Blood Pressure Regulating Pathways” collectively describes an array of regulatory mechanisms that maintain healthy blood cholesterol concentrations and arterial blood pressure. Key actors in cholesterol regulation include enzymes like HMG-CoA reductase (the rate-limiting enzyme in cholesterol biosynthesis), cholesterol transport proteins, and lipoprotein receptors such as LDL receptor. Blood pressure is governed by tightly regulated neural, endocrine, and local autoregulatory mechanisms; central among these is the renin–angiotensin–aldosterone system (RAAS), baroreceptors, and vascular smooth muscle regulatory processes. Multiple therapeutic agents target components of these pathways to prevent or treat cardiovascular diseases, but the phrase itself does not represent a singular target and is too broad to be used as a precise molecular entry[1][4][5][6]. In summary, “Cholesterol and Blood Pressure Regulating Pathways” is not a specific molecule or receptor, but refers to several interconnected physiological and biochemical systems. Accordingly, it is not a suitable canonical target entry for structured databases.

Other names

Cholesterol regulation pathwaysBlood pressure regulation pathwaysCholesterol and blood pressure homeostasis mechanismsLipid metabolism and vascular regulation pathways

Inhibition of cholesterol synthesis (statins block HMG-CoA reductase)[1][5][7]; Inhibition of cholesterol absorption (ezetimibe); Inhibition of cholesterol transport or modification of LDL/HDL function; Blockade of the renin-angiotensin-aldosterone system (RAAS) to lower blood pressure (ACE inhibitors, ARBs)[6]; Vascular smooth muscle relaxation (calcium channel blockers, nitric oxide donors)[4]; Inhibition of sympathetic tone (beta-blockers)